Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Hong Kong
/
Pharmaceuticals & Biotech
Create a narrative
WuXi Biologics (Cayman) Community
SEHK:2269 Community
1
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Create a narrative
WuXi Biologics (Cayman)
Popular
Undervalued
Overvalued
Community Investing Ideas
WuXi Biologics (Cayman)
AN
AnalystConsensusTarget
Consensus Narrative from 26 Analysts
Ireland, US And Singapore Facilities Will Transform Pharmaceutical Pipeline
Key Takeaways Strong pipeline and commercial manufacturing expansion signal robust future revenue growth and enhanced earnings potential in pharmaceutical sectors. International expansion and innovative platforms aim to boost margins and profits through efficiencies and high-margin intellectual property revenues.
View narrative
HK$28.68
FV
24.3% undervalued
intrinsic discount
14.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
2269
2269
WuXi Biologics (Cayman)
Your Fair Value
HK$
Current Price
HK$21.70
13.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
33b
2015
2018
2021
2024
2025
2027
2030
Revenue CN¥33.0b
Earnings CN¥5.9b
Advanced
Set Fair Value